Detalhe da pesquisa
1.
Circulating Tumor Cells Serve as Potential Biomarkers for Hepatocellular Carcinoma Patient with Low Alpha-Fetoprotein.
Clin Lab
; 67(11)2021 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34758232
2.
Current status and prospect of treatments for recurrent hepatocellular carcinoma.
World J Hepatol
; 15(2): 129-150, 2023 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36926237
3.
Integrative immunogenomic analysis reveals transcriptional and immune-related differences in hepatocellular carcinoma patients with different disease-free survival.
Am J Cancer Res
; 12(4): 1752-1765, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35530269
4.
Treatment of unresectable intrahepatic cholangiocarcinoma using transarterial chemoembolisation with irinotecan-eluting beads: analysis of efficacy and safety.
Cardiovasc Intervent Radiol
; 45(8): 1092-1101, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35588011
5.
DEB-TACE with irinotecan versus C-TACE for unresectable intrahepatic cholangiocarcinoma: a prospective clinical study.
Front Bioeng Biotechnol
; 10: 1112500, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36714623
6.
Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation Imaging.
Front Oncol
; 11: 743055, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34513717
7.
A rare case of hepatocellular carcinoma supplied by the left internal mammary artery treated with transarterial chemoembolization.
Asian J Surg
; 46(12): 5655-5656, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37633783